BioSpace News Archive

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced that Daniel P. Gold, Ph.D., president and chief executive officer of MEI, will present a company overview and business update at the Jefferies Virtual Healthcare Conference on Tuesday, June 2nd, 2020 at 11:00 AM Eastern Time.

Synlogic will host its first Virtual R&D Event which will include presentations from members of the Synlogic executive team providing an in-depth review of Synlogic’s Synthetic Biotic platform and programs for the treatment of metabolic diseases, inflammatory and immune disorders, and cancer.

The demand within the global market for infusion pumps has been rising on account of advancements in the domain of healthcare over the past decade, finds Transparency Market Research.

The global dental cement market was valued at approximately US$ 785.4 Mn in 2016 is projected to register cumulative annual growth rate of over 4.8% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Dental Cement Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

The mammography systems market is likely to witness promising and stable growth during 2018-2026.

The global market for cervical dysplasia features a highly consolidated competitive landscape, with the top three companies accounting for more than three-fourth of the overall market in 2017, observes a recent report by Transparency Market Research.

Radius partner Teijin Pharma has submitted a New Drug Application for abaloparatide-SC for treatment of osteoporosis in Japan

EdiGene, Inc. and Immunochina announced that they have formed a research and development collaboration to develop allogeneic CAR-T therapy for cancer.

ViewRay, Inc. announced that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian® MR-Guided Therapy System, a cutting-edge radiation therapy system that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance.

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that Company CEO Dwight Egan has been invited to present at The Role of Cell Therapy & Clarity on Testing COVID-19 virtual conference, presented by Maxim Group and M-Vest on Wednesday May 27th, 2020.